• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2005 年至 2014 年美国 2 型糖尿病患者骨质疏松症及平均骨密度趋势。

Trends in osteoporosis and mean bone density among type 2 diabetes patients in the US from 2005 to 2014.

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, University of Nevada, Las Vegas, Las Vegas, NV, 89154, USA.

Nevada Institute of Personalized Medicine, College of Science, University of Nevada, Las Vegas, Las Vegas, NV, 89154, USA.

出版信息

Sci Rep. 2021 Feb 12;11(1):3693. doi: 10.1038/s41598-021-83263-4.

DOI:10.1038/s41598-021-83263-4
PMID:33580184
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7881186/
Abstract

This study aimed to examine how bone health changed among T2DM patients in the past decade. Continuous National Health and Nutrition Examination Survey (NHANES) data from 2005-2006 to 2013-2014 were analyzed to examine the trends of bone mineral density (BMD) and the prevalence trends of osteoporosis osteopenia among T2DM patients and non-diabetic people aged 40 years and older. The age- and BMI-adjusted mean BMD of the femur neck for the four NHANES cycles decreased linearly in both T2DM patients and non-diabetic people (both P ≤ 0.009). Among women with T2DM, the mean BMD in 2013-2014 was significantly lower than that in 2005-2006, even after adjusting for multiple covariates. During 2005-2014, the prevalence of osteoporosis among T2DM patients and non-diabetic people increased but with no significant linear trend (both P > 0.05), while the prevalence of osteopenia in the two populations increased linearly (both P < 0.04). Age- and BMI-adjusted mean BMD decreased in 2013-2014 in patients with T2DM and non-diabetic people, while the prevalence of osteoporosis and osteopenia increased in both groups.

摘要

本研究旨在探讨在过去十年中,2 型糖尿病患者的骨骼健康状况发生了怎样的变化。分析了 2005-2006 年至 2013-2014 年连续的国家健康和营养检查调查(NHANES)数据,以研究 2 型糖尿病患者和年龄在 40 岁及以上的非糖尿病患者的骨密度(BMD)趋势和骨质疏松症/骨量减少的流行趋势。在四个 NHANES 周期中,经过年龄和 BMI 调整后的股骨颈平均 BMD 在 2 型糖尿病患者和非糖尿病患者中呈线性下降(均 P≤0.009)。在患有 2 型糖尿病的女性中,即使经过多变量调整后,2013-2014 年的平均 BMD 仍明显低于 2005-2006 年。2005-2014 年间,2 型糖尿病患者和非糖尿病患者的骨质疏松症患病率增加,但无显著线性趋势(均 P>0.05),而这两个群体的骨量减少患病率呈线性增加(均 P<0.04)。2013-2014 年,2 型糖尿病患者和非糖尿病患者的年龄和 BMI 调整后的平均 BMD 均下降,而两组的骨质疏松症和骨量减少的患病率均增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9515/7881186/eb07143586dd/41598_2021_83263_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9515/7881186/eb07143586dd/41598_2021_83263_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9515/7881186/eb07143586dd/41598_2021_83263_Fig1_HTML.jpg

相似文献

1
Trends in osteoporosis and mean bone density among type 2 diabetes patients in the US from 2005 to 2014.2005 年至 2014 年美国 2 型糖尿病患者骨质疏松症及平均骨密度趋势。
Sci Rep. 2021 Feb 12;11(1):3693. doi: 10.1038/s41598-021-83263-4.
2
Decreasing trend of bone mineral density in US multiethnic population: analysis of continuous NHANES 2005-2014.美国多民族人群骨密度呈下降趋势:对 2005-2014 年连续 NHANES 数据分析。
Osteoporos Int. 2018 Nov;29(11):2437-2446. doi: 10.1007/s00198-018-4648-9. Epub 2018 Aug 8.
3
Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III.美国老年人低股骨骨密度的流行率和趋势:NHANES 2005-2006 与 NHANES III 相比。
J Bone Miner Res. 2010 Jan;25(1):64-71. doi: 10.1359/jbmr.090706.
4
A positive correlation between blood glucose level and bone mineral density in Taiwan.台湾地区血糖水平与骨密度之间存在正相关关系。
Arch Osteoporos. 2018 Jul 16;13(1):78. doi: 10.1007/s11657-018-0494-9.
5
Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population.中文译文:中国人群中初诊 2 型糖尿病患者骨质疏松的相关性:一项回顾性研究。
Front Endocrinol (Lausanne). 2021 May 14;12:531904. doi: 10.3389/fendo.2021.531904. eCollection 2021.
6
Trends in Bone Mineral Density, Osteoporosis, and Osteopenia Among U.S. Adults With Prediabetes, 2005-2014.美国成年人中糖尿病前期患者的骨密度、骨质疏松症和低骨量的趋势,2005-2014 年。
Diabetes Care. 2020 May;43(5):1008-1015. doi: 10.2337/dc19-1807. Epub 2020 Mar 6.
7
Sex differences in the association between stroke and bone mineral density in elderly Koreans: The Korean National Health and Nutrition Examination Survey, 2008-2010.韩国老年人中风与骨矿物质密度之间关联的性别差异:2008 - 2010年韩国国家健康与营养检查调查
Maturitas. 2017 Jan;95:1-5. doi: 10.1016/j.maturitas.2016.10.006. Epub 2016 Oct 5.
8
Bone mineral density is associated with left ventricular diastolic function in men with type 2 diabetes.骨密度与2型糖尿病男性患者的左心室舒张功能相关。
Diabetes Metab. 2016 Sep;42(4):256-62. doi: 10.1016/j.diabet.2016.02.001. Epub 2016 Mar 10.
9
Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus.美国 1 型和 2 型糖尿病成人骨质疏松症的比较。
J Endocrinol Invest. 2018 Sep;41(9):1051-1060. doi: 10.1007/s40618-018-0828-x. Epub 2018 Jan 20.
10
Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus.中国大陆 2 型糖尿病女性患者的年龄相关性骨密度、骨质疏松发生率和椎体骨折风险。
J Endocrinol Invest. 2011 Mar;34(3):190-6. doi: 10.1007/BF03347065. Epub 2010 Aug 31.

引用本文的文献

1
HMGB1 and TLR4 as biomarkers for osteoporosis risk in type 2 diabetes mellitus: a cross-sectional study.HMGB1和TLR4作为2型糖尿病骨质疏松风险的生物标志物:一项横断面研究。
BMC Endocr Disord. 2025 Jul 14;25(1):175. doi: 10.1186/s12902-025-01998-x.
2
Epimedin B protects against bone loss and inflammation in diabetic osteoporosis rats by regulating OPG/RANKL pathway.淫羊藿苷B通过调节OPG/RANKL通路预防糖尿病性骨质疏松大鼠的骨质流失和炎症。
J Orthop Surg Res. 2025 Apr 22;20(1):403. doi: 10.1186/s13018-025-05685-4.
3
Progress in research on osteoporosis secondary to SARS-CoV-2 infection.

本文引用的文献

1
National Health and Nutrition Examination Survey, 2015-2018: Sample Design and Estimation Procedures.2015-2018 年全国健康与营养调查:样本设计和估计程序。
Vital Health Stat 2. 2020 Apr(184):1-35.
2
Trends in Bone Mineral Density, Osteoporosis, and Osteopenia Among U.S. Adults With Prediabetes, 2005-2014.美国成年人中糖尿病前期患者的骨密度、骨质疏松症和低骨量的趋势,2005-2014 年。
Diabetes Care. 2020 May;43(5):1008-1015. doi: 10.2337/dc19-1807. Epub 2020 Mar 6.
3
New directions in incidence and prevalence of diagnosed diabetes in the USA.
新型冠状病毒肺炎继发骨质疏松症的研究进展
Animal Model Exp Med. 2025 May;8(5):829-841. doi: 10.1002/ame2.12573. Epub 2025 Mar 3.
4
Ultra-processed food intake and prevalence of osteoporosis in US adults aged 50 years and older: a cross-sectional analysis.美国50岁及以上成年人的超加工食品摄入量与骨质疏松症患病率:一项横断面分析。
Osteoporos Int. 2025 Mar;36(3):455-464. doi: 10.1007/s00198-025-07394-4. Epub 2025 Jan 28.
5
Stem cell secretome restore the adipo-osteo differentiation imbalance in diabetic dental pulp-derived mesenchymal stem cells.干细胞分泌组可恢复糖尿病牙髓来源间充质干细胞中的脂肪-骨分化失衡。
Chronic Dis Transl Med. 2024 May 6;10(4):340-349. doi: 10.1002/cdt3.125. eCollection 2024 Dec.
6
A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity.探讨 2 型糖尿病(T2DM)和肥胖症中骨健康的动物模型综述。
Int J Mol Sci. 2024 Aug 29;25(17):9399. doi: 10.3390/ijms25179399.
7
Bone Fragility in Diabetes and its Management: A Narrative Review.糖尿病相关的骨骼脆弱及其管理:叙述性综述。
Drugs. 2024 Sep;84(9):1111-1134. doi: 10.1007/s40265-024-02078-5. Epub 2024 Aug 5.
8
Impact of Different Anti-Hyperglycaemic Treatments on Bone Turnover Markers and Bone Mineral Density in Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis.不同抗高血糖治疗方案对 2 型糖尿病患者骨转换标志物和骨密度的影响:系统评价和荟萃分析。
Int J Mol Sci. 2024 Jul 22;25(14):7988. doi: 10.3390/ijms25147988.
9
The single point insulin sensitivity estimator (SPISE) is associated with bone health in Arab adults.单点胰岛素敏感性估算值(SPISE)与阿拉伯成年人的骨骼健康有关。
Aging Clin Exp Res. 2024 Jun 21;36(1):136. doi: 10.1007/s40520-024-02789-5.
10
Sex- and Age-Specific Prevalence of Osteopenia and Osteoporosis: Sampling Survey.性别和年龄特异性骨量减少和骨质疏松症患病率:抽样调查。
JMIR Public Health Surveill. 2024 Apr 5;10:e48947. doi: 10.2196/48947.
美国诊断糖尿病发病率和患病率的新方向。
BMJ Open Diabetes Res Care. 2019 May 28;7(1):e000657. doi: 10.1136/bmjdrc-2019-000657. eCollection 2019.
4
Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks.2 型糖尿病发病年龄与心血管风险和死亡风险的关系。
Circulation. 2019 May 7;139(19):2228-2237. doi: 10.1161/CIRCULATIONAHA.118.037885.
5
Frailty and Risk of Fractures in Patients With Type 2 Diabetes.2 型糖尿病患者的虚弱与骨折风险。
Diabetes Care. 2019 Apr;42(4):507-513. doi: 10.2337/dc18-1965. Epub 2019 Jan 28.
6
Decreasing trend of bone mineral density in US multiethnic population: analysis of continuous NHANES 2005-2014.美国多民族人群骨密度呈下降趋势:对 2005-2014 年连续 NHANES 数据分析。
Osteoporos Int. 2018 Nov;29(11):2437-2446. doi: 10.1007/s00198-018-4648-9. Epub 2018 Aug 8.
7
Type 2 diabetes affects bone cells precursors and bone turnover.2型糖尿病会影响骨细胞前体和骨转换。
BMC Endocr Disord. 2018 Aug 8;18(1):55. doi: 10.1186/s12902-018-0283-x.
8
Diagnosis and management of bone fragility in diabetes: an emerging challenge.糖尿病患者的骨脆弱症的诊断与管理:一个新出现的挑战。
Osteoporos Int. 2018 Dec;29(12):2585-2596. doi: 10.1007/s00198-018-4650-2. Epub 2018 Jul 31.
9
Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study.2 型糖尿病与较高的小梁骨密度但较低的皮质骨密度相关:越南骨质疏松研究。
Osteoporos Int. 2018 Sep;29(9):2059-2067. doi: 10.1007/s00198-018-4579-5. Epub 2018 Jul 2.
10
Adverse effects of SGLT2 inhibitors on bone health.钠-葡萄糖协同转运蛋白 2 抑制剂对骨骼健康的不良影响。
Nat Rev Nephrol. 2018 Aug;14(8):473-474. doi: 10.1038/s41581-018-0028-0.